• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Mid-Afternoon Market Update: Nasdaq Surges 200 Points; Dentsply Sirona Shares Plunge

    4/19/22 2:41:09 PM ET
    $CMPI
    $ENSV
    $JNJ
    $REAL
    Specialty Chemicals
    Consumer Durables
    Oilfield Services/Equipment
    Energy
    Get the next $CMPI alert in real time by email

    U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Tuesday.

    The Dow traded up 1.08% to 34,783.91 while the NASDAQ rose 1.60% to 13,545.62. The S&P also rose, gaining, 1.17% to 4,442.95.

    Also check this: 4 Stocks Under $5 Insiders Are Aggressively Buying


    Leading and Lagging Sectors


    Consumer discretionary shares jumped by 2.2% on Tuesday. Meanwhile, top gainers in the sector included Sono Group N.V. (NASDAQ:SEV), up 72% and The RealReal, Inc. (NASDAQ:REAL) up 9%.


    In trading on Tuesday, energy shares fell 0.7%.


    Top Headline


    Johnson & Johnson (NYSE:JNJ) reported better-than-expected earnings for its first quarter, but suspended sales forecast for COVID-19 vaccine.

    Johnson & Johnson reported Q1 FY22 adjusted earnings of $2.67 per share, up 3.1% Y/Y and ahead of the consensus of $2.61. Net sales increased 5% Y/Y (7.9% on an operational basis) to $23.43 billion, missing the consensus of $23.67 billion.

    Johnson & Johnson expects an FY22 adjusted profit forecast of $10.15 - $10.35 per share, lower than the prior forecast of $10.40 - $10.60. The consensus estimate is $10.51. The Company expects sales of $97.3 billion – $98.3 billion, versus the consensus of $$99.31 billion. JNJ has suspended its sales forecast for the COVID-19 vaccine due to global supply surplus and demand uncertainty.


    Equities Trading UP


    Checkmate Pharmaceuticals, Inc. (NASDAQ:CMPI) shares shot up 328% to $10.40 after Regeneron announced a deal to acquire the company for $10.50 per share in cash.


    Shares of Sono Group N.V. (NASDAQ:SEV) got a boost, shooting 72% to $7.96. The company earlier issued a 2021 corporate update highlighting project deliveries and partner arrangements.


    ToughBuilt Industries, Inc. (NASDAQ:TBLT) shares were also up, gaining 40% to $0.2048 as the company posted a narrower FY21 loss.


    Equities Trading DOWN

    System1, Inc. (NYSE:SST) shares tumbled 34% to $13.53 as the company disclosed a previously-issued (from Feb. 9, 2022) shelf registration statement went into effect.


    Shares of Enservco Corporation (NYSE:ENSV) were down 15% to $3.1010. Enservco shares gained 38% on Monday after the company announced the delay of its 2021 10-K filing to adjust for its utilization of certain deferred tax liabilities in 2021.


    DENTSPLY SIRONA Inc. (NASDAQ:XRAY) was down, falling 12% to $42.72 after the company issued Q1 2022 adjusted EPS guidance below estimates and announced the appointment of John Groetelaars as Interim Chief Executive Officer.


    Also check out: Twitter And 4 Other Stocks Insiders Are Selling


    Commodities

    In commodity news, oil traded down 4.7% to $103.11, while gold traded down 1.5% to $1,956.50.


    Silver traded down 3.1% Tuesday to $25.34 while copper fell 2% to $4.7070.



    Euro zone


    European shares closed mostly lower today. The eurozone’s STOXX 600 fell 0.77%, London’s FTSE 100 fell 0.2%, while Spain’s IBEX 35 Index fell 0.06%. The German DAX slipped 0.07%, French CAC 40 fell 0.83% and Italy’s FTSE MIB Index dipped 0.96%.


    Economics


    Housing starts in the US rose 0.3% to an annualized rate of 1.793 million in March, while building permits rose 0.4% to an annual rate of 1.873 million.


    Federal Reserve Bank of Minneapolis President Neel Kashkari will speak at 8:00 p.m. ET.

    Check out this: 4 Stocks Under $5 Insiders Are Aggressively Buying


    COVID-19 Update

    The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 82,377,150 cases with around 1,015,790 deaths. India confirmed a total of at least 43,045,520 cases and 521,990 deaths, while Brazil reported over 30,261,080 COVID-19 cases with 662,070 deaths. In total, there were at least 505,279,780 cases of COVID-19 worldwide with more than 6,225,190 deaths.

     

    Get the next $CMPI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CMPI
    $ENSV
    $JNJ
    $REAL

    CompanyDatePrice TargetRatingAnalyst
    Aptera Motors Corp.
    $SEV
    3/9/2026$10.00Buy
    Alliance Global Partners
    DENTSPLY SIRONA Inc.
    $XRAY
    2/19/2026$17.00Neutral → Buy
    BofA Securities
    Johnson & Johnson
    $JNJ
    1/28/2026$262.00Equal-Weight → Overweight
    Morgan Stanley
    The RealReal Inc.
    $REAL
    12/15/2025Outperform
    William Blair
    DENTSPLY SIRONA Inc.
    $XRAY
    12/9/2025$12.00Underweight
    Barclays
    Johnson & Johnson
    $JNJ
    11/13/2025$230.00Sector Outperform
    Scotiabank
    DENTSPLY SIRONA Inc.
    $XRAY
    11/7/2025Outperform → Mkt Perform
    William Blair
    The RealReal Inc.
    $REAL
    11/5/2025$16.00Sector Weight → Overweight
    KeyBanc Capital Markets
    More analyst ratings

    $CMPI
    $ENSV
    $JNJ
    $REAL
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    July 21, 2023 - FDA Roundup: July 21, 2023

    For Immediate Release: July 21, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA Center for Tobacco Products (CTP) announced that the center will host a virtual listening session on Aug. 22, 2023. During this listening session, CTP is requesting feedback on the development of a new 5-year strategic plan for the center, includin

    7/21/23 4:02:23 PM ET
    $JNJ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    May 5, 2022 - Coronavirus (COVID-19) Update: FDA Limits Use of Janssen COVID-19 Vaccine to Certain Individuals

    For Immediate Release: May 05, 2022 Today, the U.S. Food and Drug Administration has limited the authorized use of the Janssen COVID-19 Vaccine to individuals 18 years of age and older for whom other authorized or approved COVID-19 vaccines are not accessible or clinically appropriate, and to individuals 18 years of age and older who elect to receive the Janssen COVID-19 Vaccine because they would otherwise not

    5/5/22 4:51:11 PM ET
    $JNJ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    August 18, 2021 - Joint Statement from HHS Public Health and Medical Experts on COVID-19 Booster Shots

    For Immediate Release: August 18, 2021 Today, public health and medical experts from the U.S. Department of Health and Human Services (HHS) released the following statement on the Administration’s plan for COVID-19 booster shots for the American people. The statement is attributable to Dr. Rochelle Walensky, Director of the Centers for Disease Control and Prevention (CDC); Dr. Janet Woodcock, Acting Commissione

    8/18/21 1:06:11 PM ET
    $JNJ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CMPI
    $ENSV
    $JNJ
    $REAL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Aptera Motors Reports Fourth Quarter and Full Year 2025 Financial Results

    Reports Q4 2025 GAAP Net Loss of $15.5 Million and Full Year Net Loss of $43.9 MillionCalculates Q4 2025 Adjusted Net Loss of $8.7 Million (Non-GAAP) and Full Year Adjusted Net Loss of $18.5 Million (Non-GAAP)Recognized $4.2 Million in Other Income for the Full Year, primarily from California Energy Commission GrantEnded Year with $9.6 Million in Cash and Cash Equivalents CARLSBAD, Calif., March 30, 2026 (GLOBE NEWSWIRE) -- Aptera Motors Corp. (NASDAQ:SEV) ("Aptera" or the "Company"), a solar mobility company advancing ultra-efficient transportation, today reported its financial results for the fourth quarter and full year ended December 31, 2025. "Our fourth quarter capped a transformat

    3/30/26 4:20:00 PM ET
    $SEV
    Auto Manufacturing
    Industrials

    ICOTYDE™ (icotrokinra) one-year results confirm lasting skin clearance and favorable safety profile in once‑daily pill for plaque psoriasis

    Johnson & Johnson presents new data showing high rates of complete skin clearance achieved at Week 24 and Week 52 in ICONIC-ADVANCE 1 and 2 studiesNearly 60% of adolescents treated with ICOTYDE achieved completely clear skin at Week 52 in the ICONIC-LEAD studySPRING HOUSE, Pa., March 28, 2026 /PRNewswire/ -- Johnson & Johnson (NYSE:JNJ) today announced new long-term 52-week data from the Phase 3 ICONIC-ADVANCE 1 and 2 and ICONIC-LEAD studies, which assessed the efficacy and safety of ICOTYDE™ (icotrokinra) in the treatment of patients with moderate-to-severe plaque psoriasis (PsO). ICOTYDE is the first and only targeted oral peptide that precisely blocks the IL-23 receptor.1 These data are b

    3/28/26 10:00:00 AM ET
    $JNJ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA approval of ICOTYDE™ (icotrokinra) ushers in new era for first-line systemic treatment of plaque psoriasis with a targeted oral peptide

    Johnson & Johnson introduces the first and only IL-23R targeted oral peptide that delivers complete skin clearance and favorable safety profile in a once-daily pillICOTYDE offers an innovative new option for patients with moderate-to-severe plaque psoriasis to address patients cycling on topical therapies in need of systemic treatmentSPRING HOUSE, Pa., March 18, 2026 /PRNewswire/ -- Johnson & Johnson (NYSE:JNJ) announced today that the U.S. Food and Drug Administration (FDA) has approved ICOTYDE™ (icotrokinra), an interleukin-23 (IL-23) receptor antagonist for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients 12 years of age and older who weigh at least 40

    3/18/26 7:49:00 AM ET
    $JNJ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CMPI
    $ENSV
    $JNJ
    $REAL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Alliance Global Partners initiated coverage on Aptera Motors Corp. with a new price target

    Alliance Global Partners initiated coverage of Aptera Motors Corp. with a rating of Buy and set a new price target of $10.00

    3/9/26 9:28:24 AM ET
    $SEV
    Auto Manufacturing
    Industrials

    Dentsply Sirona upgraded by BofA Securities with a new price target

    BofA Securities upgraded Dentsply Sirona from Neutral to Buy and set a new price target of $17.00

    2/19/26 7:47:02 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Johnson & Johnson upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded Johnson & Johnson from Equal-Weight to Overweight and set a new price target of $262.00

    1/28/26 7:11:28 AM ET
    $JNJ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CMPI
    $ENSV
    $JNJ
    $REAL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Lucier Gregory T bought $186,675 worth of shares (15,000 units at $12.45) (SEC Form 4)

    4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)

    3/9/26 4:20:49 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Director Forbes James D bought $62,400 worth of shares (5,000 units at $12.48), increasing direct ownership by 100% to 10,000 units (SEC Form 4)

    4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)

    3/9/26 4:19:42 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Director Lucier Gregory T bought $707,379 worth of shares (50,000 units at $14.15) (SEC Form 4)

    4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)

    3/3/26 7:12:19 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    $CMPI
    $ENSV
    $JNJ
    $REAL
    SEC Filings

    View All

    SEC Form POS AM filed by Aptera Motors Corp.

    POS AM - Aptera Motors Corp (0001786471) (Filer)

    4/2/26 4:05:23 PM ET
    $SEV
    Auto Manufacturing
    Industrials

    SEC Form POS AM filed by Aptera Motors Corp.

    POS AM - Aptera Motors Corp (0001786471) (Filer)

    4/2/26 4:05:23 PM ET
    $SEV
    Auto Manufacturing
    Industrials

    Aptera Motors Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Aptera Motors Corp (0001786471) (Filer)

    3/30/26 5:31:27 PM ET
    $SEV
    Auto Manufacturing
    Industrials

    $CMPI
    $ENSV
    $JNJ
    $REAL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Mazelsky Jonathan Jay

    4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)

    4/2/26 5:09:02 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Mccaffrey Mark

    4 - TheRealReal, Inc. (0001573221) (Issuer)

    4/2/26 4:19:05 PM ET
    $REAL
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 4 filed by Katz Karen

    4 - TheRealReal, Inc. (0001573221) (Issuer)

    4/2/26 4:15:05 PM ET
    $REAL
    Other Specialty Stores
    Consumer Discretionary

    $CMPI
    $ENSV
    $JNJ
    $REAL
    Leadership Updates

    Live Leadership Updates

    View All

    The RealReal Announces Board of Directors and Executive Leadership Updates

    SAN FRANCISCO, March 09, 2026 (GLOBE NEWSWIRE) -- The RealReal, Inc. (NASDAQ:REAL), the world's largest online marketplace for authenticated luxury resale, today announced changes to its Board of Directors and executive leadership team, further strengthening the Company's governance and operational leadership as it advances its next phase of growth. Board of Directors Update The RealReal announced the appointment of Jennifer McKeehan to its Board of Directors and the departure of Niki Leondakis from her role as a Board member, both effective March 6, 2026. McKeehan currently serves as Chief Operating Officer of Fanatics Commerce at Fanatics, Inc., and brings extensive experience leading

    3/9/26 4:05:00 PM ET
    $REAL
    Other Specialty Stores
    Consumer Discretionary

    Dentsply Sirona Appoints James Forbes and Brian McKeon to Board of Directors

    CHARLOTTE, N.C., Feb. 24, 2026 (GLOBE NEWSWIRE) --  DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced the appointments of James (Jim) D. Forbes and Brian P. McKeon to its Board of Directors (the "Board"), effective February 27, 2026. Mr. Forbes is a veteran healthcare investment banker with 30 years of experience helping companies develop strategies to drive profitable growth and long-term value creation. Mr. Forbes is widely recognized for advising healthcare companies on complex strategic transactions and capital markets engagements. He most recently served as Vice Chairman of Investment Banking at Morgan Stanley, and he previously held senior execu

    2/24/26 4:30:00 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Dentsply Sirona Appoints Donald Zurbay to Board of Directors

    CHARLOTTE, N.C., Jan. 13, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced the appointment of Donald (Don) Zurbay to its Board of Directors (the "Board"), effective January 10, 2026. He will be joining the Board's Audit and Finance Committee. Mr. Zurbay brings extensive leadership experience in the dental and healthcare industries, and value creation across complex, global organizations. He most recently served as President and Chief Executive Officer (CEO) of Patterson Companies, following his tenure as Chief Financial Officer (CFO) from 2018 to 2022. During his tenure, Patterson maintained a longstanding dealer partnership

    1/13/26 8:00:00 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    $CMPI
    $ENSV
    $JNJ
    $REAL
    Financials

    Live finance-specific insights

    View All

    System1 Announces Fourth Quarter and Full Year 2025 Financial Results

    Full Year Results Demonstrate Strength of Platform in Challenging Operating Environment Fiscal Year 2025 Financial Results: Revenue Decreased 23% Over Prior Year to $266.1 million Gross Profit Decreased 1% Over Prior Year to $100.4 million Adjusted Gross Profit Increased 1% Over Prior Year to $153.4 million Adjusted Gross Profit Margin Increased to 58% from 44% Year-Over-Year GAAP Net Loss Decreased 17% Over Prior Year to $81.2 million Adjusted EBITDA Increased 9% Over Prior Year to $41.9 million Fourth Quarter Financial Highlights: Revenue Decreased 31% Over Prior Year to $51.9 million Gross Profit Decreased 33% Over Prior Year to $21.3 million Adjusted Gros

    3/11/26 4:05:00 PM ET
    $SST
    Computer Software: Programming Data Processing
    Technology

    Johnson & Johnson to Host Investor Conference Call on First-Quarter Results

    Johnson & Johnson (NYSE:JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, April 14th to review first-quarter results. Joaquin Duato, Chairman and Chief Executive Officer, Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Darren Snellgrove, Vice President, Investor Relations will host the call. The question and answer portion of the call will also include additional members of Johnson & Johnson's executive team. Investors and other interested parties can access the webcast/conference call in the following ways: The webcast and presentation material are accessible at Johnson & Johnson's website www.investor.jnj.com. A replay of

    3/2/26 4:30:00 PM ET
    $JNJ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    The RealReal Announces Fourth Quarter and Full Year 2025 Results

    Company surpassed $2 billion in GMV, accelerated active buyer growth, and exceeded 2025 financial guidance SAN FRANCISCO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- The RealReal, Inc. (NASDAQ:REAL)—the world's largest online marketplace for authenticated, resale luxury goods—today reported financial results for its fourth quarter and full year ended December 31, 2025. Fourth quarter 2025 gross merchandise value (GMV) and total revenue increased 22% and 18%, respectively, compared to the fourth quarter of 2024. Full year 2025 GMV and total revenue increased 16% and 15% respectively, compared to the full year for 2024. Fourth quarter Adjusted EBITDA was $22 million, or 11.3% of total revenue, which

    2/26/26 4:03:00 PM ET
    $REAL
    Other Specialty Stores
    Consumer Discretionary

    $CMPI
    $ENSV
    $JNJ
    $REAL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Enservco Corporation

    SC 13D/A - Enservco Corp (0000319458) (Subject)

    12/10/24 4:00:16 PM ET
    $ENSV
    Oilfield Services/Equipment
    Energy

    Amendment: SEC Form SC 13G/A filed by DENTSPLY SIRONA Inc.

    SC 13G/A - DENTSPLY SIRONA Inc. (0000818479) (Subject)

    12/6/24 10:11:29 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by ToughBuilt Industries Inc.

    SC 13G/A - Toughbuilt Industries, Inc (0001668370) (Subject)

    11/14/24 7:29:15 PM ET
    $TBLT
    Industrial Machinery/Components
    Consumer Discretionary